212 related articles for article (PubMed ID: 15274387)
1. Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis and patient survival in ovarian cancer.
Li L; Wang L; Zhang W; Tang B; Zhang J; Song H; Yao D; Tang Y; Chen X; Yang Z; Wang G; Li X; Zhao J; Ding H; Reed E; Li QQ
Anticancer Res; 2004; 24(3b):1973-9. PubMed ID: 15274387
[TBL] [Abstract][Full Text] [Related]
2. [Study on serum vascular endothelial growth factor level in ovarian malignant tumors].
Li L; Wang LM; Zhang W; Zhang JQ; Song HL; Yao DS; Tang Y; Chen XQ; Yang ZH
Zhonghua Fu Chan Ke Za Zhi; 2003 Feb; 38(2):72-6. PubMed ID: 12783691
[TBL] [Abstract][Full Text] [Related]
3. Prognostic relevance of serum vascular endothelial growth factor in ovarian cancer.
Oehler MK; Caffier H
Anticancer Res; 2000; 20(6D):5109-12. PubMed ID: 11326678
[TBL] [Abstract][Full Text] [Related]
4. Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer.
Cooper BC; Ritchie JM; Broghammer CL; Coffin J; Sorosky JI; Buller RE; Hendrix MJ; Sood AK
Clin Cancer Res; 2002 Oct; 8(10):3193-7. PubMed ID: 12374688
[TBL] [Abstract][Full Text] [Related]
5. Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group.
Werther K; Christensen IJ; Brünner N; Nielsen HJ
Eur J Surg Oncol; 2000 Nov; 26(7):657-62. PubMed ID: 11078612
[TBL] [Abstract][Full Text] [Related]
6. The potential clinical relevance of serum vascular endothelial growth factor (VEGF) and VEGF-C in recurrent papillary thyroid carcinoma.
Yu XM; Lo CY; Lam AK; Lang BH; Leung P; Luk JM
Surgery; 2008 Dec; 144(6):934-40; discussion 940-1. PubMed ID: 19041000
[TBL] [Abstract][Full Text] [Related]
7. Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma.
Yu XM; Lo CY; Lam AK; Leung P; Luk JM
Ann Surg; 2008 Mar; 247(3):483-9. PubMed ID: 18376194
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of quantitative analysis of serum VEGF, CD44s, and MMP-3 protein in nasopharyngeal carcinoma].
Li YH; Shao JY; Li S; Zou BY; Huang HQ; Guan ZZ
Ai Zheng; 2004 Sep; 23(9):1060-4. PubMed ID: 15363202
[TBL] [Abstract][Full Text] [Related]
10. Serum vascular endothelial growth factor-C and lymphoangiogenesis are associated with the lymph node metastasis and prognosis of patients with colorectal cancer.
Wang TB; Chen ZG; Wei XQ; Wei B; Dong WG
ANZ J Surg; 2011 Oct; 81(10):694-9. PubMed ID: 22295309
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between serum VEGF level and VEGF, COX-2 and MVD expression in breast cancer tissues].
Li EX; Wu YY; Shi F; Wu Y; Guo JJ; Dong DF
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):522-5. PubMed ID: 18069633
[TBL] [Abstract][Full Text] [Related]
12. The clinical relevance of serum vascular endothelial growth factor (VEGF) in correlation to circulating tumor cells and other serum biomarkers in patients with metastatic breast cancer.
Banys-Paluchowski M; Witzel I; Riethdorf S; Pantel K; Rack B; Janni W; Fasching PA; Aktas B; Kasimir-Bauer S; Hartkopf A; Solomayer EF; Fehm T; Müller V
Breast Cancer Res Treat; 2018 Nov; 172(1):93-104. PubMed ID: 30003393
[TBL] [Abstract][Full Text] [Related]
13. Serum vascular endothelial growth factor in epithelial ovarian neoplasms: correlation with patient survival.
Chen CA; Cheng WF; Lee CN; Chen TM; Kung CC; Hsieh FJ; Hsieh CY
Gynecol Oncol; 1999 Aug; 74(2):235-40. PubMed ID: 10419737
[TBL] [Abstract][Full Text] [Related]
14. [Serum level and expression of vascular epithelial growth factor in ovarian epithelial carcinoma].
Sun LX; Wu Y; Han HQ; Wang QH
Ai Zheng; 2003 Jan; 22(1):58-61. PubMed ID: 12561438
[TBL] [Abstract][Full Text] [Related]
15. Prospective validation of the prognostic value of elevated serum vascular endothelial growth factor in patients with nasopharyngeal carcinoma: more distant metastases and shorter overall survival after treatment.
Lv X; Xiang YQ; Cao SM; Qian CN; Li NW; Guo L; Mai HQ; Chen QY; Huang PY; Luo D; Cao KJ; Hong MH; Guo X
Head Neck; 2011 Jun; 33(6):780-5. PubMed ID: 20967862
[TBL] [Abstract][Full Text] [Related]
16. Serum preoperative vascular endothelial growth factor (VEGF) in epithelial ovarian cancer: relationship with prognostic variables and clinical outcome.
Gadducci A; Ferdeghini M; Fanucchi A; Annicchiarico C; Ciampi B; Prontera C; Genazzani AR
Anticancer Res; 1999; 19(2B):1401-5. PubMed ID: 10365113
[TBL] [Abstract][Full Text] [Related]
17. [The relationship between lymphatic metastasis and serum vascular endothelial growth factor C and cyclooxygenase 2 expression in breast cancer].
Li EX; Shi F; Wu YY; Wu Y; Guo JJ; Dong DF
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):88-91. PubMed ID: 18353210
[TBL] [Abstract][Full Text] [Related]
18. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
Baron AT; Lafky JM; Boardman CH; Balasubramaniam S; Suman VJ; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810
[TBL] [Abstract][Full Text] [Related]
19. Serum vascular endothelial growth factor-C combined with multi-detector CT in the preoperative diagnosis of lymph node metastasis of gastric cancer.
Wang TB; Wang J; Wei XQ; Wei B; Dong WG
Asia Pac J Clin Oncol; 2012 Jun; 8(2):180-6. PubMed ID: 22524577
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
